Vaginal microbiota transplantation is a truly opulent and promising edge: fully grasp its potential
Authors:
Top Cited Papers
Open Access
- 22 March 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1280636
Abstract
Vaginal microbiota transplantation (VMT) is a cutting-edge treatment modality that has the potential to revolutionize the management of vaginal disorders. The human vagina is a complex and dynamic ecosystem home to a diverse community of microorganisms. These microorganisms play a crucial role in maintaining the health and well-being of the female reproductive system. However, when the balance of this ecosystem is disrupted, it can lead to the development of various vaginal disorders. Conventional treatments, such as antibiotics and antifungal medications, can temporarily relieve the symptoms of vaginal disorders. However, they often fail to address the underlying cause of the problem, which is the disruption of the vaginal microbiota. In recent years, VMT has emerged as a promising therapeutic approach that aims to restore the balance of the vaginal ecosystem. Several studies have demonstrated the safety and efficacy of VMT in treating bacterial vaginosis, recurrent yeast infections, and other vaginal conditions. The procedure has also shown promising results in reducing the risk of sexually transmitted infections and preterm birth in pregnant women. However, more research is needed to establish optimal donor selection, preparation, and screening protocols, as well as long-term safety and efficacy. VMT offers a safe, effective, and minimally invasive treatment option for women with persistent vaginal problems. It could improve the quality of life for millions of women worldwide and become a standard treatment option shortly. With further research and development, it could potentially treat a wide range of other health problems beyond the scope of vaginal disorders.Keywords
This publication has 63 references indexed in Scilit:
- Sodium alginate hydrogel integrated with type III collagen and mesenchymal stem cell to promote endometrium regeneration and fertility restorationInternational Journal of Biological Macromolecules, 2023
- Effectiveness and Costs of Molecular Screening and Treatment for Bacterial Vaginosis to Prevent Preterm BirthJAMA Pediatrics, 2023
- Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparityImmunity, 2023
- Fecal microbiota transplantation holds the secret to youthMechanisms of Ageing and Development, 2023
- Intrapartum amnioinfusion reduces meconium aspiration syndrome and improves neonatal outcomes in patients with meconium-stained fluid: a systematic review and meta-analysisAmerican Journal of Obstetrics and Gynecology, 2023
- Oral administration of maternal vaginal microbes at birth to restore gut microbiome development in infants born by caesarean section: A pilot randomised placebo-controlled trialEBioMedicine, 2021
- Dysbiosis of the rat vagina is efficiently rescued by vaginal microbiota transplantation or probiotic combinationInternational Journal of Antimicrobial Agents, 2021
- Bacterial vaginosis: Standard treatments and alternative strategiesInternational Journal of Pharmaceutics, 2020
- Ecological dynamics of the vaginal microbiome in relation to health and diseaseAmerican Journal of Obstetrics and Gynecology, 2019
- Colonization of the upper genital tract by vaginal bacterial species in nonpregnant womenAmerican Journal of Obstetrics and Gynecology, 2015